Cardiothoracic Surgery

The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

  • Coronary artery bypass surgery
  • Valve repair/replacement
  • Surgery for adult congenital heart disease
  • Minimally Invasive Heart Surgery
  • Ventricular Assist Devices (VADs)
Learn More
Cardiac Surgery team

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

  • Lung and esophageal cancers
  • Emphysema
  • Hyperhidrosis
  • Hiatal hernia
  • Pericardial & Pleural Effusions
  • Thoracentesis
Learn More
Thoracic Surgery team

Why Choose Weill Cornell?

New Advances

Study Looks at the “Harms” of Lung Cancer Screening

By Brendon M. Stiles, MD

May 7, 2018

It was a privilege to present our clinical research, “Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice?” at the 98th American Association of Thoracic Surgery (AATS) Annual Meeting last week in San Diego. I was pleased that the AATS recognized the importance of our message by placing the presentation in one of the featured plenary sessions.

Here is a link to the article: "Study Looks at the "Harms" of Ling Cancer Screening"

The First New York Regional Symposium on Marfan Syndrome and Related Disorders

The symposium is intended to offer people living with Marfan syndrome and related disorders, and their families, support as well as information about their health. For more details: NYC Marfan Syndrome and Related Disorders Symposium

Department of Health: Adult Cardiac Surgery in NYS 2013-2015

Weill Cornell Medicine continues to be the leader in Coronary Artery Bypass Graft (CABG), Valve Repair and Replacement Surgery, and TAVR in achieving the best results among NYS hospitals.  The NYS Cardiac Data Reporting System sets standards for Cardiac Services and monitors their outcomes all across New York State.   New York State’s intention is to share performance data with all health care providers, patients and families of patients who are contemplating cardiac surgery (including Mortality Rate for the surgery and following surgery, Readmission Rates, Volume of cases, descriptions of patients’ risk factors associated with mortality for surgery).

Please click on the link to find the reports related to CABG; Valve/CABG; Valves, TAVR

Never Smokers: The New Face of Lung Cancer

By Brendon M. Stiles, MD, FACS

March 9, 2018

People often use the expression, “Where there is smoke, there is fire.” Unfortunately for lung cancer patients, the opposite is almost always assumed to be true. Where there is fire (in this case, lung cancer), it is assumed that smoking must have preceded it. This assumption often leads to the question, “Did you smoke?” following almost every personal revelation of lung cancer. Few questions engender such anger and annoyance in patients as that one, particularly in the 10%-20% of lung cancer patients who are “never smokers.”

Here is a link to the article: Never Smokers: The New Face of Lung Cancer

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.

Current Clinical Trials

 

US News National 2017-18

The Weill Cornell Medicine's Department of Cardiothoracic Surgery is proud to partner with NewYork-Presbyterian, ranked #3 in Adult Cardiology & Heart Surgery Hospital in the nation and #1 in NYC by U.S. News and World Report.